HIPRA Launches New Combined Vaccine

Suiseng® is the new combined vaccine against neonatal piglet diarrhoea caused by E. coli and Clostridium perfringens type C and sudden death of sows caused by Clostridium novyi. The vaccine incorporates a new generation adjuvant based on ginseng saponins: Hipramune®-G.

The vaccine is launched onto the European Union market using a decentralized registration process. With this new product, Hipra and its R&D department clearly show their involvement in the search for innovative solutions to everyday problems of veterinarians and farmers and it is launched at both the key national and international markets for global livestock production.

Suiseng incorporates a new generation water-based ginseng saponin adjuvant that induces more powerful immunity than conventional water-based vaccines with maximum safety for the animals, thus becoming an innovative and exclusive vaccine within its market.

Suiseng is available in 10, 25 and 50-dose presentations.

Further Reading

-

Find out more information on the diseases mentioned in this article by clicking here.

ThePigSite News Desk

Sign up for our
regular news updates

Related news items:

•    Third TOPIGS Import into China in Three Months
•    OleoServ Takes over Harles & Jentzsch Assets
•    Nutreco Achieves Excellent Progress in 2011
•    New Zealand Pork Seeks New CEO
•    Two Cases of ASF in Wild Boar

Related News Categories: Pig Health, Company/Products

Sign up for our
regular news updates

More of the latest Pig Industry News

•   CME: Changes for Beef, Pork & Poultry Supplies
•   Action Taken to Ramp Up Abattoir Inspections
•   FAO Food Price Index Rebounds in January
•   US Pork Export Forecast is Unchanged
•   Public Resistance Ousts GM Crops From EU
•   Animal Welfare: The Right Thing to Do
•   2011 Pork Imports Higher Than a Year Ago
•   New Way to Map Drought and Water Use
•   Nutreco CEO to Step Down at End of 2012
•   Importers Face High Stocks & Weak Demand